Indication
Leukocyte adhesion deficiency type 1 (LAD-1)
Leukocyte adhesion deficiency type 1 (LAD-1) is a rare, life-threatening autosomal recessive primary immunodeficiency disorder caused by pathogenic variants in the *ITGB2* gene, which encodes the beta-2 integrin subunit CD18. Read more about Leukocyte adhesion deficiency type 1 (LAD-1)
1 drugs 1 manufacturers
Drugs that treat it
Common Leukocyte adhesion deficiency type 1 (LAD-1) therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLeukocyte adhesion deficiency type 1 (LAD-1) is a rare, life-threatening autosomal recessive primary immunodeficiency disorder caused by pathogenic variants in the *ITGB2* gene, which encodes the beta-2 integrin subunit CD18.
This genetic defect disrupts leukocyte adhesion and prevents neutrophils from transmigrating across vascular endothelium into infected or inflamed tissues.
Characterized primarily in pediatric populations, hallmark clinical features include delayed separation of the umbilical cord, severe omphalitis, impaired wound healing, persistent peripheral blood leukocytosis, and recurrent, non-purulent bacterial and fungal infections affecting the skin and mucous membranes.
- medlineplus.gov
Leukocyte adhesion deficiency type 1 (LAD-1) is a rare, life-threatening autosomal recessive primary immunodeficiency disorder caused by pathogenic variants in the *ITGB2* gene, which encodes the beta-2 integrin subunit CD18 Characterized primarily in pediatric populations, hallmark clinical features include delayed separation of the umbilical cord, severe omphalitis, impaired wound healing, persistent peripheral blood leukocytosis, and recurrent, non-purulent bacterial and fungal infections aff...
- nih.gov
Leukocyte adhesion deficiency type 1 (LAD-1) is a rare, life-threatening autosomal recessive primary immunodeficiency disorder caused by pathogenic variants in the *ITGB2* gene, which encodes the beta-2 integrin subunit CD18
- nih.gov
Leukocyte adhesion deficiency type 1 (LAD-1) is a rare, life-threatening autosomal recessive primary immunodeficiency disorder caused by pathogenic variants in the *ITGB2* gene, which encodes the beta-2 integrin subunit CD18
- nih.gov
This genetic defect disrupts leukocyte adhesion and prevents neutrophils from transmigrating across vascular endothelium into infected or inflamed tissues
- nih.gov
This genetic defect disrupts leukocyte adhesion and prevents neutrophils from transmigrating across vascular endothelium into infected or inflamed tissues
- nih.gov
Characterized primarily in pediatric populations, hallmark clinical features include delayed separation of the umbilical cord, severe omphalitis, impaired wound healing, persistent peripheral blood leukocytosis, and recurrent, non-purulent bacterial and fungal infections affecting the skin and mucous membranes
Personalize your experience
Follow Leukocyte adhesion deficiency type 1 (LAD-1) and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.